Previous 10 | Next 10 |
Citing a "lack of clarity" regarding its ability to meet certain requirements under its loan with Vatera Investment Partners LLC, Melinta Therapeutics (NASDAQ: MLNT ) discloses that it will unable to draw additional funds under the $135M loan. More news on: Melinta Therapeutics, Inc., He...
WASHINGTON , July 1, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of X-Biotix Therapeutics, Inc. (X-Biotix) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new additi...
Melinta Therapeutics (MLNT) is a pharmaceutical company specialising in the development of treatments for bacterial infections. On Wednesday, June 19, we saw a huge spike in the stock price from $2 to over $6 at one point on news that the FDA had accepted a supplemental New Drug Application ((...
On June 19 th , 2019 Melinta Therapeutics ( MLNT ) announced the FDA accepted its BAXDELA sNDA for priority review. This sNDA would expand BAXDELA's label to include adult patients with community-acquired bacterial pneumonia (CABP). The FDA gave BAXDELA a 6-month review cycle and a PDUFA dat...
Gainers: Axovant Gene Therapies (NASDAQ: AXGT ) +40% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +24% . India Globalization Capital (NYSEMKT: IGC ) +17% . Pintec Technology (NASDAQ: PT ) +14% . ObsEva SA (NASDAQ: OBSV ) +12% . Overstock.com (NASDAQ: OSTK ) +12% . Fuwei Films (NASDAQ...
Melinta Therapeutics ( MLNT ) stock soared more than 200% on Wednesday, after it had announced that its supplemental New Drug Application (sNDA) was accepted by the FDA . The application seeks to expand the market opportunity for its drug BAXDELA. What also caused the stock to soar higher...
WASHINGTON , June 20, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug-resistant infections and spur life-saving innovations, today announced that eleven of its member companies will present data from their clinical...
Guardion Health Sciences (NASDAQ: GHSI ) +35% on receiving a patent from the European Union for its proprietary medical device, the MapcatSF. More news on: Guardion Health Sciences, Inc., DiaMedica Therapeutics Inc., Melinta Therapeutics, Inc., Stocks on the move, Read more .....
MLNT stock more than tripled following Melinta Therapeutics Inc (NASDAQ:MLNT) announcing that its supplemental New Drug Application (sNDA) for Baxdela was approved by the FDA. Big Day for MLNT Stock Connecticut-based Melinta Therapeutics, which is involved in the development and marketi...
Gainers: Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...
News, Short Squeeze, Breakout and More Instantly...
Melinta Therapeutics Inc - Ordinary Shares Company Name:
MLNT Stock Symbol:
NASDAQ Market:
Melinta Therapeutics Inc - Ordinary Shares Website:
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. (“Purch...
Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotic...
Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company Continues Operations with No Anticipated Disruption to Product Supply or Support MO...